Salvage methods for recurrent prostate cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Prostate Cell Line, Tumor Tumor Cells, Cultured Epithelial Cells Neoplastic Stem Cells Chromosomes, Human, Pair 8 Seminal Vesicles Rectum Stromal Cells Neoplastic Cells, Circulating

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Mice, Transgenic

Diseases36

Prostatic Neoplasms Neoplasm Recurrence, Local Recurrence Prostatic Hyperplasia Neoplasms, Hormone-Dependent Neoplasm Metastasis Disease Progression Adenocarcinoma Bone Neoplasms Prostatic Intraepithelial Neoplasia Neoplasm Invasiveness Genetic Predisposition to Disease Breast Neoplasms Neoplasms Carcinoma Lung Neoplasms Ovarian Neoplasms Prostatic Neoplasms, Castration-Resistant Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Prostatic Diseases Pancreatic Neoplasms Prostatitis Urinary Bladder Neoplasms Neovascularization, Pathologic Colorectal Neoplasms Uterine Cervical Neoplasms Disease Models, Animal Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplastic Cells, Circulating Rectal Neoplasms Erectile Dysfunction Radiation Injuries Ischemia

Chemicals and Drugs70

Prostate-Specific Antigen Receptors, Androgen Androgen Antagonists Dihydrotestosterone 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Androgens Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Androgen Receptor Antagonists Neoplasm Proteins Anilides RNA, Messenger Finasteride Metribolone Flutamide RNA, Small Interfering Taxoids Anticarcinogenic Agents Cancer Vaccines Glutamate Carboxypeptidase II 5-alpha Reductase Inhibitors PTEN Phosphohydrolase DNA, Neoplasm Antineoplastic Agents, Phytogenic Testosterone Congeners Antigens, Neoplasm Androstenols Testosterone Azasteroids Proto-Oncogene Proteins c-akt Phenylthiohydantoin Nitriles Racemases and Epimerases RNA, Neoplasm Tumor Suppressor Protein p53 Transcription Factors Cholestenone 5 alpha-Reductase MicroRNAs Estramustine Leuprolide Tumor Suppressor Proteins Goserelin Receptor, erbB-2 Glutathione S-Transferase pi Antibodies, Monoclonal Paclitaxel Receptors, Estrogen DNA-Binding Proteins Enzyme Inhibitors Cisplatin Proto-Oncogene Proteins Prostatic Secretory Proteins DNA Primers Androgen-Binding Protein Proto-Oncogene Proteins c-bcl-2 Kallikreins Steroid 17-alpha-Hydroxylase Oncogene Proteins, Fusion Insulin-Like Growth Factor Binding Protein 3 Fluorouracil Carotenoids Ki-67 Antigen Receptor, Epidermal Growth Factor Trans-Activators Nuclear Proteins Cadherins Protein Kinase Inhibitors Radiopharmaceuticals

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Prostatectomy Salvage Therapy Cryotherapy Radioimmunoassay Immunohistochemistry Limb Salvage Retrospective Studies Orchiectomy Early Detection of Cancer Neoplasm Staging Neoplasm Grading Prognosis Treatment Outcome Risk Factors Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Digital Rectal Examination Follow-Up Studies Neoplasm Transplantation Survival Rate Survival Analysis Transplantation, Heterologous Prospective Studies Blotting, Western Case-Control Studies Combined Modality Therapy Risk Assessment Gene Expression Profiling Risk Antineoplastic Combined Chemotherapy Protocols Transurethral Resection of Prostate Disease-Free Survival Biopsy Brachytherapy Sensitivity and Specificity Biopsy, Needle Odds Ratio Cohort Studies Incidence Kaplan-Meier Estimate Transfection Tumor Burden Multivariate Analysis Predictive Value of Tests Oligonucleotide Array Sequence Analysis Radiotherapy Tissue Array Analysis Registries Castration Radiotherapy, Conformal SEER Program Radiotherapy Dosage Logistic Models Polymerase Chain Reaction Nomograms Reproducibility of Results Drug Screening Assays, Antitumor Molecular Targeted Therapy Operative Blood Salvage Questionnaires Models, Biological Clinical Trials as Topic Confidence Intervals Treatment Failure Mass Screening Gene Knockdown Techniques Disease Models, Animal Flow Cytometry Immunoenzyme Techniques Proportional Hazards Models Radiotherapy, Intensity-Modulated Amputation Chemotherapy, Adjuvant Radiotherapy Planning, Computer-Assisted Drug Administration Schedule In Situ Hybridization, Fluorescence Immunotherapy ROC Curve Genetic Therapy Real-Time Polymerase Chain Reaction Radiotherapy, Adjuvant Radiotherapy, Image-Guided

Psychiatry and Psychology2

Smoking Erectile Dysfunction

Phenomena and Processes43

Gene Expression Regulation, Neoplastic Cell Proliferation Apoptosis Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Signal Transduction Cell Growth Processes Time Factors Sensitivity and Specificity Down-Regulation Genotype Cell Division Cell Survival Odds Ratio Cell Movement Transfection DNA Methylation Up-Regulation Promoter Regions, Genetic Dose-Response Relationship, Drug Cell Cycle Mutation Polymorphism, Genetic Gene Silencing Nomograms Gene Fusion Genes, Tumor Suppressor RNA Interference Chromosomes, Human, Pair 8 Base Sequence Gene Expression Phosphorylation Diet Polymorphism, Single Nucleotide Transcription, Genetic Alleles Genes, Neoplasm Phenotype Drug Synergism Germ-Line Mutation Radiation Tolerance Oncogene Fusion

Disciplines and Occupations3

Immunohistochemistry Medical Oncology Urology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science10

Survival Rate Incidence Registries Radiotherapy, Conformal SEER Program Questionnaires Base Sequence Molecular Sequence Data Radiotherapy, Intensity-Modulated Radiotherapy Planning, Computer-Assisted

Named Groups4

European Continental Ancestry Group African Americans Survivors African Continental Ancestry Group

Health Care34

Retrospective Studies Treatment Outcome Risk Factors Follow-Up Studies Watchful Waiting Survival Rate Survival Analysis Prospective Studies Case-Control Studies Risk Assessment Risk Disease-Free Survival Sensitivity and Specificity Odds Ratio Cohort Studies Incidence Kaplan-Meier Estimate Multivariate Analysis Predictive Value of Tests Registries Age Factors National Cancer Institute (U.S.)SEER Program Logistic Models Nomograms Reproducibility of Results Questionnaires Clinical Trials as Topic Confidence Intervals Treatment Failure Mass Screening Proportional Hazards Models ROC Curve Radiation Injuries

Geographicals3

United States Sweden Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Prostate-Specific Antigen Prostate Neoplasm Recurrence, Local Prostatectomy Salvage Therapy Receptors, Androgen Androgen Antagonists Cryotherapy Dihydrotestosterone 3-Oxo-5-alpha-Steroid 4-Dehydrogenase Androgens Recurrence Radioimmunoassay Immunohistochemistry Cell Line, Tumor Limb Salvage Retrospective Studies Prostatic Hyperplasia Gene Expression Regulation, Neoplastic Orchiectomy Neoplasms, Hormone-Dependent Early Detection of Cancer Neoplasm Metastasis Tumor Markers, Biological Disease Progression Adenocarcinoma Mice, Nude Bone Neoplasms Prostatic Intraepithelial Neoplasia Tosyl Compounds Neoplasm Staging Neoplasm Invasiveness Neoplasm Grading Prognosis Antineoplastic Agents Cell Proliferation Antineoplastic Agents, Hormonal Tumor Cells, Cultured Apoptosis Genetic Predisposition to Disease Androgen Receptor Antagonists Treatment Outcome Risk Factors Neoplasm Proteins Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Digital Rectal Examination Follow-Up Studies Anilides RNA, Messenger Watchful Waiting Neoplasm Transplantation Breast Neoplasms Survival Rate Finasteride Survival Analysis Transplantation, Heterologous Prospective Studies Neoplasms Blotting, Western Case-Control Studies Drug Resistance, Neoplasm Combined Modality Therapy Carcinoma Lung Neoplasms Risk Assessment Gene Expression Profiling Risk Metribolone Antineoplastic Combined Chemotherapy Protocols Transurethral Resection of Prostate Signal Transduction Ovarian Neoplasms Cell Growth Processes Disease-Free Survival Biopsy Time Factors Prostatic Neoplasms, Castration-Resistant Flutamide Brachytherapy RNA, Small Interfering Taxoids Anticarcinogenic Agents Sensitivity and Specificity United States Down-Regulation Genotype Cell Division Cancer Vaccines Cell Survival Glutamate Carboxypeptidase II Colonic Neoplasms Biopsy, Needle Mice, SCID 5-alpha Reductase Inhibitors Odds Ratio Cohort Studies Incidence PTEN Phosphohydrolase

No FAQ available that match "salvage methods for recurrent prostate cancer"